BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tondepu C, Karumbaiah L. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma. Adv Healthc Mater 2022;11:e2101956. [PMID: 34878733 DOI: 10.1002/adhm.202101956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sallam M, Mysara M, Baatout S, Guns PJ, Ramadan R, Benotmane MA. Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma. Cancers (Basel) 2022;14. [PMID: 36497269 DOI: 10.3390/cancers14235788] [Reference Citation Analysis]
2 Lin S, Tan Z, Cui H, Ma Q, Zhao X, Wu J, Dai L, Kang H, Guan F, Dai Z. Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer. Front Oncol 2022;12:854284. [DOI: 10.3389/fonc.2022.854284] [Reference Citation Analysis]
3 Silsirivanit A. Glycan and Glycosylation as a Target for Treatment of Glioblastoma. Glioblastoma - Current Evidences [Working Title] 2022. [DOI: 10.5772/intechopen.106044] [Reference Citation Analysis]
4 Xie Y, Lu X, Wang Z, Liu M, Liu L, Wang R, Yang K, Xiao H, Li J, Tang X, Liu H. A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma. Biomater Sci 2022. [DOI: 10.1039/d2bm01145j] [Reference Citation Analysis]